Prudential Financial’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-63,979
| Closed | -$2.09M | – | 2772 |
|
|
2022
Q2 | $2.09M | Sell |
63,979
-2,025
| -3% | -$64K | ﹤0.01% | 1367 |
|
|
2022
Q1 | $1.74M | Sell |
66,004
-49,733
| -43% | -$1.21M | ﹤0.01% | 1579 |
|
|
2021
Q4 | $2.75M | Sell |
115,737
-94,858
| -45% | -$2.34M | ﹤0.01% | 1360 |
|
|
2021
Q3 | $5.28M | Sell |
210,595
-56,715
| -21% | -$1.45M | 0.01% | 964 |
|
|
2021
Q2 | $6.95M | Sell |
267,310
-48,195
| -15% | -$1.31M | 0.01% | 898 |
|
|
2021
Q1 | $8.08M | Buy |
315,505
+39,147
| +14% | +$1M | 0.01% | 847 |
|
|
2020
Q4 | $5.54M | Sell |
276,358
-52,020
| -16% | -$1.02M | 0.01% | 961 |
|
|
2020
Q3 | $5.63M | Sell |
328,378
-213,753
| -39% | -$4.04M | 0.01% | 884 |
|
|
2020
Q2 | $11.8M | Buy |
542,131
+67,197
| +14% | +$1.54M | 0.02% | 636 |
|
|
2020
Q1 | $11M | Buy |
474,934
+37,804
| +9% | +$1.1M | 0.02% | 596 |
|
|
2019
Q4 | $14.4M | Buy |
437,130
+220,084
| +101% | +$7.05M | 0.02% | 708 |
|
|
2019
Q3 | $6.91M | Buy |
217,046
+161,735
| +292% | +$4.71M | 0.01% | 975 |
|
|
2019
Q2 | $1.42M | Sell |
55,311
-5,240
| -9% | -$134K | ﹤0.01% | 1747 |
|
|
2019
Q1 | $1.54M | Buy |
60,551
+1,861
| +3% | +$55.5K | ﹤0.01% | 1723 |
|
|
2018
Q4 | $2M | Buy |
58,690
+2,859
| +5% | +$93K | ﹤0.01% | 1517 |
|
|
2018
Q3 | $1.99M | Sell |
55,831
-590
| -1% | -$20.8K | ﹤0.01% | 1622 |
|
|
2018
Q2 | $1.95M | Buy |
56,421
+490
| +0.9% | +$17.2K | ﹤0.01% | 1657 |
|
|
2018
Q1 | $1.88M | Sell |
55,931
-21,200
| -27% | -$671K | ﹤0.01% | 1612 |
|
|
2017
Q4 | $2.95M | Sell |
77,131
-130,030
| -63% | -$5.19M | ﹤0.01% | 1403 |
|
|
2017
Q3 | $7.77M | Sell |
207,161
-17,870
| -8% | -$631K | 0.01% | 980 |
|
|
2017
Q2 | $8.39M | Buy |
225,031
+139,130
| +162% | +$5.03M | 0.01% | 949 |
|
|
2017
Q1 | $3.37M | Buy |
85,901
+12,790
| +17% | +$480K | 0.01% | 1300 |
|
|
2016
Q4 | $2.54M | Sell |
73,111
-3,050
| -4% | -$120K | ﹤0.01% | 1421 |
|
|
2016
Q3 | $2.99M | Sell |
76,161
-22,230
| -23% | -$887K | ﹤0.01% | 1313 |
|
|
2016
Q2 | $3.72M | Sell |
98,391
-18,840
| -16% | -$631K | 0.01% | 1260 |
|
|
2016
Q1 | $4.5M | Sell |
117,231
-103,800
| -47% | -$3.87M | 0.01% | 1150 |
|
|
2015
Q4 | $10.6M | Sell |
221,031
-44,500
| -17% | -$2.06M | 0.02% | 775 |
|
|
2015
Q3 | $10.5M | Sell |
265,531
-32,500
| -11% | -$1.38M | 0.02% | 727 |
|
|
2015
Q2 | $12.7M | Sell |
298,031
-4,300
| -1% | -$171K | 0.02% | 723 |
|
|
2015
Q1 | $11.9M | Buy |
302,331
+39,000
| +15% | +$1.44M | 0.02% | 763 |
|
|
2014
Q4 | $9.49M | Buy |
263,331
+103,200
| +64% | +$3.47M | 0.02% | 733 |
|
|
2014
Q3 | $4.72M | Buy |
160,131
+12,111
| +8% | +$334K | 0.01% | 976 |
|
|
2014
Q2 | $3.72M | Buy |
148,020
+23,259
| +19% | +$575K | 0.01% | 1169 |
|
|
2014
Q1 | $3.22M | Buy |
124,761
+27,700
| +29% | +$698K | 0.01% | 1200 |
|
|
2013
Q4 | $2.18M | Sell |
97,061
-1,800
| -2% | -$34.8K | ﹤0.01% | 1409 |
|
|
2013
Q3 | $1.4M | Sell |
98,861
-20,409
| -17% | -$273K | ﹤0.01% | 1592 |
|
|
2013
Q2 | $1.63M | Buy |
+119,270
| New | +$1.63M | ﹤0.01% | 1488 |
|
Other funds holding NTUS
Prudential Financial's NTUS Position: Q3 2022 in Review
Prudential Financial sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 63,979 shares — an estimated $2.09M sold.
Prudential Financial first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $14.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Prudential Financial reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Prudential Financial sold 63,979 Natus Medical Inc shares in Q3 2022, an estimated $2.09M.
- Prudential Financial first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- Prudential Financial's Natus Medical Inc position peaked at $14.4M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Prudential Financial's 13F filing for Q3 2022, filed 4 Nov 2022.